Anthropic Builds the Autonomous AI Lab. Why AI Drug Research is Becoming a Growth Driver for Thermo Fisher

The new life sciences initiative by Anthropic strengthens my optimism for Thermo Fisher, which has been in the US model portfolio since $600. The company is a winner in the biotechnology AI revolution. Anthropic has set up its own wet lab in the San Francisco area and aims to increasingly link Claude with real biological experiments. This takes the AI revolution in drug research to the next step from the computer to the lab. Claude can already design protein binders. In an Anthropic test, successful binders were created for 14 out of 15 targets,...